Notice No.   20230515-2   Notice Date   15 May 2023
Category   Company related   Segment   Equity
Subject   Discontinuance of Buyback of the shares of Natco Pharma Limited (Scrip code: 524816)

 This is in continuation of the Exchange Notice No:    20230320-2 dated March 20, 2023, Trading Members are hereby informed that Natco Pharma Limited (Scrip code: 524816) has now informed to the Exchange about discontinuation of the Buyback of its fully paid-up equity shares of face value of Re. 2/- each from the Open Market through the trading mechanism of the Exchange w.e.f. May 12, 2023.


In case trading members require any clarification, they may contact Mr. Raghavendra Bhat on Tel. no. (022) 2272 8915.



Rupal Khandelwal

Assistant General Manager

Monday, May 15, 2023